These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13498003)

  • 1. A study of the clinical and metabolic effects of 9 alpha-fluoro-11 beta-hydroxy-17 alpha-methyltestosterone (fluoxymesterone).
    McGAVACK TH; SEEGERS W
    Am J Med Sci; 1958 Feb; 235(2):125-32. PubMed ID: 13498003
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of anabolic steroids in humans: synthesis of 6 beta-hydroxy metabolites of 4-chloro-1,2-dehydro-17 alpha-methyltestosterone, fluoxymesterone, and metandienone.
    Schänzer W; Horning S; Donike M
    Steroids; 1995 Apr; 60(4):353-66. PubMed ID: 8539789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the androgenic activity of 9-alpha-fluoro-11-beta-hydroxy-17-methyltestosterone ('ultandren') I. Effects of 'ultandren' on three seminal vesicles, coagulating glands and epididymides of the adult castrate rat.
    CLEGG EJ; FARLEY TM
    J Reprod Fertil; 1962 Oct; 4():125-30. PubMed ID: 14040703
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the androgenic activity of 9-alpha-fluoro-11beta-hydroxy-17-methyltestosterone ('ultandren') I. Effects of 'ultandren' on thee seminal vesicles, coagulating glands and epididymides of the adult castrate rat.
    CLEGG EJ; FARLEY TM
    J Reprod Fertil; 1962 Oct; 4():125-30. PubMed ID: 14041468
    [No Abstract]   [Full Text] [Related]  

  • 5. [Opposite effects of hydrocortisone and 9-alpha-fluoro-11-beta-hydroxy-17-alpha-methyltestosterone on the rat adrenal gland].
    JOST A; GRANDOU P
    C R Seances Soc Biol Fil; 1958; 152(6):896-8. PubMed ID: 13609073
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the androgenic activity of 9alpha-fluoro-11beta-hydroxy-17-methyltestosterone ('ultandren') II. A comparison between the androgenic properties of 'ultadren' and testosterone propionate.
    CLEGG EJ; FARLEY TM
    J Reprod Fertil; 1962 Oct; 4():131-6. PubMed ID: 14040704
    [No Abstract]   [Full Text] [Related]  

  • 7. COMPARISON OF 6-ALPHA-METHYL-9-ALPHA-FLUORO-17-ACETOXY-21-DEOXYPREDNISOLONE WITH FLUOXYMESTERONE AND METHYLPREDNISOLONE IN TREATMENT OF METASTATIC BREAST CANCER.
    TALLEY RW; BRENNAN MJ; VAITKEVICIUS VK; SANDIEGO EL; REED ML; LEIGHTON GA
    Cancer; 1964 Aug; 17():1063-6. PubMed ID: 14202593
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxymesterone; a new oral androgen.
    BUCKLE RM
    Br Med J; 1959 May; 1(5134):1378-82. PubMed ID: 13651739
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoxymesterone in the treatment of advanced breast cancer.
    KENNEDY BJ
    Cancer; 1957; 10(4):813-8. PubMed ID: 13472624
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of fluoxymesterone and methyltestosterone administered orally in the hypophysectomized male rat].
    KRAHENBUHL C
    Acta Endocrinol (Copenh); 1961 Jul; 37():394-404. PubMed ID: 13753869
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of fluoxymesterone and methyltestosterone as growth stimulants.
    MELLMAN WJ; BONGIOVANNI AM; GARRISON M; STEIKER DD
    Pediatrics; 1961 Oct; 28():525-30. PubMed ID: 14472402
    [No Abstract]   [Full Text] [Related]  

  • 12. CLINICAL EVALUATION OF A NEW ANABOLIC AGENT 7-ALPHA,17-ALPHA-DIMETHYLTESTOSTERONE (BOLASTERONE).
    KORST DR; BOWERS CY; FLOKSTRA JH; MCMAHON FG
    Clin Pharmacol Ther; 1963; 4():734-9. PubMed ID: 14079251
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation.
    TALLEY RW; BRENNAN MJ; VAITKEVICIUS VK; BECKETT VL
    Cancer; 1963 Apr; 16():440-3. PubMed ID: 13984784
    [No Abstract]   [Full Text] [Related]  

  • 14. THE RATIO OF ANABOLIC TO ANDROGENIC ACTIVITY OF 7:17-DIMETHYLTESTOSTERONE, OXYMESTERONE, MESTANOLONE AND FLUOXYMESTERONE.
    ARNOLD A; POTTS GO; BEYLER AL
    J Endocrinol; 1963 Dec; 28():87-92. PubMed ID: 14086172
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxymesterone therapy in advanced breast cancer.
    KENNEDY BJ
    N Engl J Med; 1958 Oct; 259(14):673-5. PubMed ID: 13590423
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary experience with fluoxymesterone in gynecological therapy.
    MARZIALE P; MITTIGA M; HECHTLUCARI G
    Clin Ostet Ginecol; 1959 Feb; 61(1):47-54. PubMed ID: 13652421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anabolic agents (synthetic androgens) in oncology, with special reference to breast carcinoma].
    PIACENTINI G
    Clin Ter; 1962 Aug; 23():197-214. PubMed ID: 13943190
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of erythropoiesis by androgenic hormones.
    KENNEDY BJ
    Ann Intern Med; 1962 Dec; 57():917-36. PubMed ID: 14031936
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progestational properties of 9-alpha-fluoro-11-beta-hydroxy-17-alpha-methyitestosterone].
    JOST A
    Ann Endocrinol (Paris); 1958; 19(3):584-7. PubMed ID: 13559793
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intersexuality of the calf fetus produced by androgens. Comparison between the fetal hormone responsible for free-martinism and the adult testicular hormone].
    JOST A; CHODKIEWICZ M; MAULEON P
    C R Hebd Seances Acad Sci; 1963; 256():274-6. PubMed ID: 14042012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.